Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

98.12 +2.59 (+2.71%)
Official Closing Price Updated: 4:10 PM EDT, Sep 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
2 Beaten-Down Stocks With Stable Dividends to Buy In 2023
You can bet the farm on these companies' dividends. 
Via The Motley Fool
3 Unstoppable Dividend Stocks to Buy in February
All three belong to the elite group of stocks known as Dividend Kings. 
Via The Motley Fool
2 Top Dividend Growth Stocks to Buy in February
They don't offer the highest yields, but these strongly profitable businesses are poised to raise their payouts at a blistering pace. 
Via The Motley Fool
5 Top Stocks to Buy Now
This eclectic mix of stocks will help diversify your portfolio. 
Via The Motley Fool
Sector Shift Stalls Healthcare Stocks But Biotech Shows Gains In January
Biotech stocks are off to a great start in 2023 with the IBB up 4.5% and the XBI up 7.7%. 
Via Talk Markets
What 5 Analyst Ratings Have To Say About Abbott Laboratories
Via Benzinga
Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years
Via Benzinga
What's Going On With Abbott Laboratories Stock Today?
Abbott Laboratories (NYSE: ABT) shares are trading lower Wednesday in the wake of the company's quarterly results. 
Via Benzinga
Abbott Laboratories Skids As Covid Testing Weighs On Organic Growth
Overall sales topped forecasts, but organic growth missed expectations. 
Via Investor's Business Daily
GE Healthcare Technology: Speculating On Dividends
GE Healthcare released a solid report and gave steady guidance that includes ample room in the cash flow for a dividend, should the board choose to pay one. 
Via MarketBeat
Is Abbott Laboratories a Good Dividend Stock to Buy Now?
At least four Wall Street banks recently raised their price targets for the healthcare giant. 
Via The Motley Fool
Stock Market Rally Powers Higher Amid Big Earnings From Tesla, Boeing, Microsoft, American Express: Weekly Review
Stocks reacted well to uneven earnings and economic reports. 
Via Investor's Business Daily
A Bullish Sign Appears On Abbott Laboratories's Chart
Via Benzinga
Earnings Outlook For Abbott Laboratories
Via Benzinga
NIKE To Rally Over 23%? Here Are 10 Other Analyst Forecasts For Thursday
Keybanc raised the price target for D.R. Horton, Inc. (NYSE: DHI) from $97 to $109. Keybanc analyst Kenneth Zener maintained an Overweight rating. D.R. Horton shares fell 1.6% to close at $95.48 on... 
Via Benzinga
Abbott's Sales and Earnings Are Sinking: Should Investors Worry?
There's more to the story than the negative trends for Abbott's top and bottom lines. 
Via The Motley Fool
Two Dividend Kings: Johnson & Johnson or Abbott Laboratories?
Johnson & Johnson and Abbott Laboratories are 2 dividend kings guiding for growth in 2023 and are on track to increase their yield yet again. 
Via MarketBeat
Topics Economy
Exposures Interest Rates
Why Abbott Laboratories Stock Got Whacked on Wednesday
Double beats for its latest quarter couldn't keep the bears away from the company's shares on Hump Day. 
Via The Motley Fool
Abbott Laboratories (ABT) Q4 2022 Earnings Call Transcript
ABT earnings call for the period ending December 31, 2022. 
Via The Motley Fool
Why Aurora Cannabis Stock Is Fading Today
With discretionary spending under pressure, investors are shying away from this Canadian cannabis stock today. 
Via The Motley Fool
Abbott Q4 Earnings And Revenues Top Estimates
Abbott came out with quarterly earnings of $1.03 per share. 
Via Talk Markets
Microsoft's Gloomy Guidance, Boeing's Surprise Q4 Loss Pulls Market Lower
(Wednesday Market Open) The market gives and the market takes away. 
Via Benzinga
Nasdaq Futures Slump As Microsoft's Outlook Dampens Tech Recovery Expectations — Analyst Warns Of More Bumpiness By Mid-February
U.S. stocks look set to start Wednesday’s session on the back foot as traders digest mixed earnings news flow and continued pouring in of weak economic data points. Cues From Tuesday’s Trading: 
Via Benzinga
Earnings Scheduled For January 25, 2023
Companies Reporting Before The Bell • ASML Holding (NASDAQ:ASML) is expected to report quarterly earnings at $4.45 per share on revenue of $6.50 billion. 
Via Benzinga
Investor Optimism Declines Following Earnings Reports
The CNN Money Fear and Greed index showed some decline in overall market sentiment among US investors. US stocks closed mixed on Tuesday as investors assessed the latest corporate earnings. 
Via Benzinga
Abbott Laboratories, QUALCOMM, GE HealthCare Technologies And This Subsidiary Of Diamondback Energy On CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management named Viper Energy Partners LP (NASDAQ: VNOM), which is a subsid 
Via Benzinga
Stocks Make a Quiet Move Upward Ahead of Thursday's GDP, 'Pause' Talk
(Monday Market Open) This week and next could go a long way toward determining how the current quarter plays out on Wall Street. 
Via Benzinga
Spotify To Downsize Employee Count, Activist Investor Elliott Invests Multibillion Dollars In Salesforce, Abbott Draws DOJ Investigation On Baby Formula Plant Shutdown: Today's Top Stories
Reuters Juul's Consumer Settlement Is 'Reasonable & Adequate,' US Judge Says 
Via Benzinga
Want Safe and Growing Passive Income? Buy These 2 Dividend Kings In 2023
It doesn't get any safer for income investors than Dividend Kings. 
Via The Motley Fool
6 Dividend Growth Stocks
Interested in knowing about companies that are paying their shareholders even bigger dividends than before? Today I want to tell you about six dividend growth stocks that just increased their... 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.